Skip to main content
. 2016 Oct 26;22:1267–1279.

Table 2. Clinical findings of Turkish LCD1 and GCD1 patients carrying TGFBI variations.

Patient no Age/Sex Diagnosis Family history Consanguinity Age at diagnosis BCVA (OD/OS) Treatment Variation
1
28/F
LCD1
+
-
18
0.8/0.7
-
R124C/-
2
23/F
LCD1
-
-
18
0.2/0.4
-
R124C/-
3
45/M
LCD1
+
-
24
0.05/0.4
OD ALK
R124C/-
4
40/M
LCD1
-
-
20
0.4/0.5
OD-OS PTK
R124C/-
5
36/F
GCD1
+
+
15
0.05/0.05
OD PPK
R555W/-
6
35/M
GCD1
+
+
20
0.05/0.3
-
R555W/-
7
18/F
GCD1
+
-
10
0.9/0.8
-
R555W/-
8
53/M
GCD1
+
-
30
0.4/0.4
-
R555W/-
9
27/M
GCD1
+
-
20
0.05/0.05
OD-OS ALK
R555W/R555W
10
42/F
GCD1
+
+
18
0.3/0.4
-
R555W/-
11
26/M
GCD1
-
-
18
0.5/0.3
OS PTK
R555W/-
12
54/F
GCD1
+
-
30
0.6/0.5
-
R555W/-
13
40/M
GCD1
+
-
20
0.1/0.2
OD ALK
R555W/-
14
43/M
GCD1
+
+
15
0.05/0.05
OD-OS PPK
R555W/-
15
35/F
GCD1
-
-
20
0.4/0.3
-
R555W/-
16 33/F GCD1 + - 18 0.8/0.7 - R555W/-.

OD: Right eye; OS: Left eye; ALK: Anterior lamellar keratoplasty; PPK: Partial penetrating keratoplasty, PTK: Phototheraupetic keratectomy, NA: Nonavailable